• A brief history and challenges of clozapine utilization in the Arab world 

      Monica, Zolezzi; Eltorki, Yassin ( Elsevier , 2023 , Article)
      Clozapine synthesis dates back to 1958, when a Swiss pharmaceutical company produced it based on the chemical structure of the tricyclic antidepressant imipramine (Crilly, 2007; Idänpään-Heikkilä et al., 1975). Clinical ...
    • Clozapine prescribing and safety during COVID-19 

      Wadoo, Ovais; Karim, Mustafa Abdul; ElTorki, Yassin; Riaz, Sadaf; Latoo, Javed; ... more authors ( Elsevier , 2021 , Other)
      Schizophrenia is a chronic mental disorder affecting 20 million people worldwide (James et al., 2018). Clozapine remains the most effective pharmacological treatment for schizophrenia but requires regular blood monitoring ...
    • Clozapine prescribing practice and trends in Qatar: First national observational study 

      Wadoo, Ovais; Latoo, Javed; Alabdulla, Majid; Eltorki, Yassin; Riaz, Sadaf; ... more authors ( John Wiley and Sons Ltd , 2022 , Article)
      Background: Clozapine is the gold standard in the management of treatment-resistant schizophrenia. Despite its clinically proven efficacy clozapine utilization is variable globally and published evidence is suggestive of ...
    • Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis 

      Wilby, Kyle John; Johnson, Eric G.; Johnson, Hannah E.; Ensom, Mary H.H. ( SAGE Publications Inc. , 2017 , Article Review)
      Objective: To summarize and evaluate the existing literature regarding medications to treat Parkinson's disease (PD) psychosis. Data Sources: MEDLINE (1946 to March 2017), EMBASE (1980 to March 2017), CINAHL (1982 to March ...